Literature DB >> 17955241

Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.

Dominik Dytfeld, Magdalena Matuszak, Krzysztof Lewandowski, Mieczysław Komarnicki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17955241     DOI： 10.1007/s00277-007-0401-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment.

Authors:  Soo-Young Bae; Jae-Sook Ahn; Deok-Hwan Yang; Yeo-Kyeoung Kim; Jung-Joon Min; Ho-Chun Song; Hee-Seung Bom; Yong Yeon Jeong; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2011-02-25

2.  Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report.

Authors:  Deirdre F Waterhouse; Geraldine A Moloney; Fatma S Gargoum; Peter S Hayden; Tom O'Gorman
Journal:  Cases J       Date:  2009-09-14

3.  Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report.

Authors:  Anup Kasi Loknath Kumar; Christopher Dakhil; Megha Teeka Satyan; Nisreen Haideri
Journal:  J Med Case Rep       Date:  2014-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.